Diabetes stands for a kind of disease, especially diabetes mellitus, characterized by super high levels of glucose (sugar) in the blood. The product categories for this condition’s management fall within glucose monitoring devices (e.g. lancets, blood glucose meters) and insulin administration devices (e.g. insulin pumps, pens and syringes).
Globally, the Diabetes Care Market trends toward approaching far over EUR 19 billion by end-2018. The market will primarily be jet-propelled by the universal upsurge in the diabetes-stricken population, and the fast adoption tempos of less or non-invasive breakthroughs, including, among others, the EyeSense's blood glucose monitoring (BGM) devices, NBM-200G, 8 MediSensors' optical glucose monitoring technologies, Easy Check’s breath-based glucose testers. The dominating vendors in this marketplace include Roche, LifeScan, Sanofi, Novo Nordisk, Bayer Diabetes, and Lilly.
The research reports within the confines of this Catalogue analyze the Diabetes Care Market’s performance in a worldwide scenario, as well as across different geographies. The researches extensively review major market trends, driving forces and restraints for giving a clearer idea of the market structure. Additionally, the reports give unbiased insights into the competitive environment, major producers of anti-diabetic medications and diabetes devices, key products marketed and those currently in development. The global Diabetes Care Market forecasts are also available in the research reports.
Publications found:
8
Sort by:
Global Feed Grade Inositol Market Growth 2026-2032
US$ 3,660.00
The global Feed Grade Inositol market size is predicted to grow from US$ 61.41 million in 2025 to US$ 80.1 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032. Feed grade inosi...
September 2026
93 pages
Global Smart Insulin Delivery Patch Market Growth 2026-2032
US$ 3,660.00
The global Smart Insulin Delivery Patch market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The Smart Insulin Deli...
August 2026
121 pages
Global Contact-Activated Lancet Market Growth 2026-2032
US$ 3,660.00
The global Contact-Activated Lancet market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Contact-activated lancets,...
August 2026
108 pages
Smart Insulin Delivery Devices Market Forecasts To 2034 – Global Analysis By Device Type (Smart Insulin Pens, Smart Insulin Pumps, Smart Insulin Patch Pumps, Automated Insulin Delivery Systems and Connected Insulin Delivery Devices), Technology, Delivery Mechanism, Component, Connectivity Type, Patient Type, Distribution Channel, Application, End User and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Smart Insulin Delivery Devices Market is accounted for $1.1 billion in 2026 and is expected to reach $2.7 billion by 2034 growing at a CAGR of 11.8% during the...
August 2026
200 pages
